Circulation · 1999 · 228 citations · 19 references
Veterinary MedicineCardiologyInfectious DiseasesClinical CardiologyInflammationInnate ImmunityCoronary Artery DiseaseEndothelial ActivationInflammation In Infectious DiseaseInflammatory MediatorsInflammatory SignalingThrombosisCytokine Expression RegulationEndothelial Contribution To ThrombosisEndothelial Procoagulant ActivityInflammation In Cardiovascular DiseaseInflammation-associated ThrombosisPlasminogen ActivatorsTissue Factor ActivationVascular Endothelial Function
BACKGROUND: Recent reports link C. pneumoniae infection of arteriosclerotic lesions to the precipitation of acute coronary syndromes, which also feature tissue factor and plasminogen activator inhibitor 1 (PAI-1) overexpression. We investigated whether or not C. pneumoniae can induce thrombogenicity by upregulation of procoagulant proteins. METHODS AND RESULTS: Human vascular endothelial and smooth muscle cells were infected with a strain of C. pneumoniae isolated from an arteriosclerotic coronary artery. Tissue factor, PAI-1, and interleukin-6 expression was increased in infected cells. Concomitantly, NF-kappaB was activated and IkappaBalpha degraded. p50/p65 heterodimers were identified as the components responsible for the NF-kappaB activity. CONCLUSIONS: These data provide evidence that C. pneumoniae infection can induce procoagulant protein and proinflammatory cytokine expression. This cellular response is accompanied by activation of NF-kappaB. Our results demonstrate how C. pneumoniae infection may initiate acute coronary syndromes.
19
Sally J. Dawson, B. Wiman, Anders Hamsten et al. · Journal of Biological Chemistry · 1993 · 569 citations · Full text
Matthias Maass, Claus Bartels, Peter M. Engel et al. · Journal of the American College of Cardiology · 1998 · 364 citations